Ablation is a kind of minimally invasive surgery, categorized into microwave ablation and radiofrequency ablation, which is currently an important means of non-surgical treatment for liver cancer. The survival rate of treated patients may vary from person to person, which is closely related to the severity of the disease, whether it is treated in time or not, and their own health condition.
1. Primary liver cancer patients with mild disease and timely and effective ablation treatment have the possibility of being cured with good postoperative recovery and good health condition, and the 5-year survival rate of such patients is about 30% to 50%.
2. If the condition is more serious, advanced or metastatic, and combined with cirrhosis and rupture of liver cancer, the survival rate can be greatly reduced, and the median survival time of patients is about 7-16 months. The median survival time of patients is about 7-16 months. After secondary liver cancer is treated by ablation therapy, the five-year survival rate is about 25%-46%.
3. Survival rate after ablation for liver cancer cannot be generalized. Early stage liver cancer or limited liver metastases with diameter <3cm have the possibility of complete eradication, and there is no obvious difference between 5-year survival rate and surgical treatment.
4. For advanced liver cancer, it can be one of the integrated treatments of multimodal therapy, which can help patients significantly improve the quality of survival and prolong the survival period.
It is recommended to choose suitable treatment means and standardize treatment under the guidance of doctors.